MODIFIED HIV ENVELOPE ANTIGENS AND METHOD OF USE THEREOF

63/368,507 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed July 15, 2022
Case Type Provisional
Status Provisional Application Expired
Child PCT/US23/70242 Published
Last Updated: 6 months, 3 weeks ago
Date # Transaction
7/16/2023EXPIRED PROVISIONAL
7/26/2022Filing ReceiptAPP.FILE.REC PUBLIC PROSECUTION
7/26/2022Email Notification
7/26/2022Application ready for PDX access by participating foreign offices
7/26/2022Application Is Now Complete
7/26/2022Filing Receipt
7/25/2022Application Dispatched from OIPE
7/25/2022Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
7/15/2022Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE)SCORE PUBLIC PROSECUTION
7/15/2022SpecificationSPEC PUBLIC PROSECUTION
7/15/2022ClaimsCLM PUBLIC PROSECUTION
7/15/2022AbstractABST PUBLIC PROSECUTION
7/15/2022Electronic Fee PaymentN417.PYMT PUBLIC PROSECUTION
7/15/2022Application Data SheetADS PUBLIC PROSECUTION
7/15/2022Provisional Cover Sheet (SB16)TR.PROV PUBLIC PROSECUTION
7/15/2022Electronic Filing System Acknowledgment ReceiptN417 PUBLIC PROSECUTION
7/15/2022Drawings-other than black and white line drawingsDRW.NONBW PUBLIC PROSECUTION
7/15/2022PTO/SB/69-Authorize EPO Access to Search Results
7/15/2022Applicants have given acceptable permission for participating foreign
7/15/2022Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
7/15/2022Initial Exam Team nn